Andrew Cooper

Stock Analyst at Raymond James

(0)
# 4090
Out of 5,245 analysts
148
Total ratings
47.42%
Success rate
-5.08%
Average return
24 Stocks
Name Action Price Target Current % Upside Ratings Updated
Haemonetics
Upgrades: Strong Buy
120 120
73.61 63.02% 7 Nov 8, 2024
Revvity
Maintains: Outperform
144 146
118.28 23.44% 5 Nov 5, 2024
Hologic
Maintains: Outperform
93 95
69.81 36.08% 10 Nov 5, 2024
Danaher
Maintains: Outperform
310 300
238.33 25.88% 6 Oct 23, 2024
Exact Sciences
Reiterates: Market Perform
n/a
n/a n/a 8 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
650 660
559.66 17.93% 5 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 16 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
68 85
158.38 -46.33% 5 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
100 76
41.72 82.17% 12 Feb 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 26
22.11 17.59% 12 Jan 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
27
36.7 -26.43% 2 Nov 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1 1
n/a n/a 10 Aug 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 14 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 7 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 27
12.38 118.09% 3 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 8 Jan 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
17.12 162.85% 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
31 39
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
145 225
n/a n/a 4 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
20
n/a n/a 1 Mar 18, 2020